At present, we lack understanding of the risk ...

For immediate release: Monday, May 17, 2011

Boston, MA Men who regularly drink coffee appears to lower risk of developing deadly form of prostate cancer, according to new research led by the Harvard School of Public Health (HSPH) researchers. What's more, the lower risk was evident among men who drank either regular or decaffeinated coffee. The study was published May 17, 2011, in the online edition of the

Journal of the National Cancer Institute. A few studies have specifically studied the levaquin 400 mg association of coffee consumption and risk of fatal prostate cancer, the form of the disease, which is the most important preventable. Our study is the largest to date to examine the issue of coffee may reduce the risk of fatal prostate cancer, said lead author, assistant professor of epidemiology at HSPH. Lethal prostate cancer is cancer that causes death or spreads to the bones. Prostate cancer is the most frequently diagnosed cancer and second leading cause of cancer death among U.S. men, affecting one in six men during their lifetime. More than 2 million people in the U.S. and 16 million men around the world surviving prostate cancer. At present we lack an understanding of risk factors that may be changed or controlled to reduce the risk of fatal prostate cancer. If our data is verified, coffee may be a modifiable factor that may reduce the risk of the most harmful forms of prostate cancer, said lead author, researcher in the field of epidemiology at HSPH. The researchers chose to study coffee because it contains many useful compounds, which act as antioxidants, reduce inflammation, and regulate insulin, all of which can affect prostate cancer.